Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's
Pharma
Amid stagnant sales, Biogen touts progress on new launches
The question at Biogen isn’t so much how the company’s doing now, but what its plans are for future growth, its CEO said on a call with investors.
Fraiser Kansteiner
Nov 8, 2023 11:29am
A look at FDA's Aduhelm approval and regulatory bias
Oct 27, 2023 8:00am
Eisai launches Theoria to build out a 'dementia ecosystem'
Sep 13, 2023 8:10am
Sen. Sanders warns about price of Eisai, Biogen's Leqembi
Jul 12, 2023 3:05pm
Otsuka, Lundbeck head into FDA panel with agency support
Apr 13, 2023 9:30am
'The Top Line': 2023's obesity market and 2022's drug approvals
Feb 3, 2023 6:00am
